Quetiapine not beneficial for delirium prevention in older patients: Study

Written By :  Medha Baranwal
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2021-04-13 03:30 GMT   |   Update On 2021-04-13 03:49 GMT
Advertisement

Thailand: Quetiapine is not beneficial for delirium prevention in hospitalized older medical patients, finds a recent study in the journal BMC Geriatrics. According to the study, quetiapine prophylaxis did not reduce delirium incidence in this population group.

Delirium is a common disorder among hospitalized older patients and results in increased mortality and morbidity. Delirium prevention is challenging in older patient care. Antipsychotics' role in the prevention of delirium is limited. Taweevat Assavapokee, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand, and colleagues, therefore, conducted a trial to investigate the efficacy of quetiapine use to prevent delirium in hospitalized older medical patients.

For the purpose, the researchers conducted a randomized double-blind controlled trial at Ramathibodi Hospital, Bangkok. It enrolled 122 patients aged ≥65 years hospitalized in the internal medicine service. Patients were randomized to receive quetiapine 12.5 mg (n=57) or placebo (n=57) once daily at bedtime for a maximum 7-day duration.

The primary endpoint was delirium incidence. Secondary endpoints were delirium duration, length of hospital stay, ICU admission, rehospitalization, and mortality within 30 and 90 days. 

Key findings of the study include:

  • The delirium incidence rates in the quetiapine and placebo groups were 14.0 and 8.8% (OR = 1.698), respectively.
  • Other endpoints in the quetiapine and placebo groups were the median length of hospital stay, 6 days versus 5 days, respectively; delirium duration, 4 versus 3 days, respectively; ICU admission, 3 (5.3%) patients from both groups; and mortality in the quetiapine and placebo groups, 1 (1.8%) versus 2 (3.5%) at 30 days and 7 (12.3%) versus 9 (15.8%) days at 90 days.
  • There were no significant differences in other outcomes.
  • None of the participants reported adverse events.

"Quetiapine prophylaxis did not reduce delirium incidence in hospitalized older medical patients," wrote the authors. "The use of quetiapine to prevent delirium in this population group should not be recommended."

Reference:

The study titled, "Efficacy of quetiapine for delirium prevention in hospitalized older medical patients: a randomized double-blind controlled trial," is published in the journal BMC Geriatrics.

DOI: https://bmcgeriatr.biomedcentral.com/articles/10.1186/s12877-021-02160-7#Sec16

Tags:    
Article Source : BMC Geriatrics

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News